文献速递糖尿病

糖尿病患者血清25-羟基维生素D浓度与全因及病因特异性死亡率的关联

Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes.
PubMed 文献 · Diabetes Care · 2020-11-08

本研究基于NHANES III与2001-2014中6,329例糖尿病成人,随访至2015年底,采用Cox比例风险模型分析血清25(OH)D与全因、心血管病及癌症死亡率的关联。结果显示较高的25(OH)D水平与较低的全因死亡和心血管病死亡风险显著相关,呈线性关系。

要点

  • 血清25(OH)D每增加一个自然对数单位,全因死亡风险降低31%,心血管病死亡风险降低38%。
  • 与25(OH)D<25 nmol/L者相比,>75 nmol/L者全因死亡HR为0.59(95%CI 0.43-0.83)。
  • 维生素D缺乏(<50 nmol/L)在糖尿病成人中占46.6%,维持充足水平可能降低死亡风险。

核心结论

  • 较高的血清25(OH)D水平与糖尿病患者较低的全因死亡和心血管病死亡风险显著相关。
  • 维持充足的维生素D状态可能降低糖尿病患者的死亡风险。

研究设计与样本

  • 研究纳入来自第三次全国健康与营养调查(NHANES III)和NHANES 2001-2014的6,329例糖尿病成人。
  • 通过链接至2015年12月31日的国家死亡指数记录确定死亡结局。
  • 采用Cox比例风险模型估计全因、心血管病和癌症死亡的风险比(HR)及95%CI。

主要发现

  • 血清25(OH)D加权均值(95%CI)为57.7(56.6, 58.8)nmol/L,46.6%的参与者存在维生素D缺乏(<50 nmol/L)。
  • 基线时较高的血清25(OH)D水平与较低的血糖、胰岛素、胰岛素抵抗HOMA指数、HbA1c、血脂和C反应蛋白水平显著相关(所有P趋势<0.05)。
  • 随访55,126人年期间记录2,056例死亡,包括605例心血管病死亡和309例癌症死亡。
  • 多变量调整后,血清25(OH)D每增加一个自然对数单位,全因死亡风险降低31%,心血管病死亡风险降低38%(均P<0.001)。
  • 与25(OH)D<25 nmol/L者相比,>75 nmol/L者的多变量调整HR(95%CI)为:全因死亡0.59(0.43, 0.83)(P趋势=0.003),心血管病死亡0.50(0.29, 0.86)(P趋势=0.02),癌症死亡0.49(0.23, 1.04)(P趋势=0.12)。

临床怎么用

  • 在糖尿病管理中可关注血清25(OH)D水平,对缺乏者考虑纠正,以可能降低全因和心血管病死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The evidence regarding vitamin D status and mortality among people with diabetes is scarce. This study aimed to examine the association of serum 25-hydroxyvitamin D [25(OH)D] concentrations with all-cause and cause-specific mortality among adults with diabetes. RESEARCH DESIGN AND METHODS: This study included 6,329 adults with diabetes from the Third National Health and Nutrition Examination Survey (NHANES III) and NHANES 2001-2014. Death outcomes were ascertained by linkage to National Death Index records through 31 December 2015. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% CIs for mortality from all causes, cardiovascular disease (CVD), and cancer. RESULTS: The weighted mean (95% CI) level of serum 25(OH)D was 57.7 (56.6, 58.8) nmol/L, and 46.6% had deficient vitamin D (<50 nmol/L [20 ng/mL]). Higher serum 25(OH)D levels were significantly associated with lower levels of glucose, insulin, HOMA of insulin resistance, HbA1c, blood lipids, and C-reactive protein at baseline (all P trend < 0.05). During 55,126 person-years of follow-up, 2,056 deaths were documented, including 605 CVD deaths and 309 cancer deaths. After multivariate adjustment, higher serum 25(OH)D levels were significantly and linearly associated with lower all-cause and CVD mortality: there was a 31% reduced risk of all-cause mortality and a 38% reduced risk of CVD mortality per one-unit increment in natural log-transformed 25(OH)D (both P < 0.001). Compared with participants with 25(OH)D <25 nmol/L, the multivariate-adjusted HRs and 95% CI for participants with 25(OH)D >75 nmol/L were 0.59 (0.43, 0.83) for all-cause mortality (P trend = 0.003), 0.50 (0.29, 0.86) for CVD mortality (P trend = 0.02), and 0.49 (0.23, 1.04) for cancer mortality (P trend = 0.12). CONCLUSIONS: Higher serum 25(OH)D levels were significantly associated with lower all-cause and CVD mortality. These findings suggest that maintaining adequate vitamin D status may lower mortality risk in individuals with diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wan Z, Guo J, Pan A, et al. Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes. Diabetes Care. 2020. PMID: 33168652. doi:10.2337/dc20-1485

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。